Bone Biologics (BBLG): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Bone Biologics Corporation (BBLG)

The lack of sales and clinic expenses drive the dynamics of Bone Biologics (BBLG), as illustrated by the cash balance on the balance sheet, where the figure stood at 0.00. The innovative NELL-1 tissue regeneration platform creates growth potential within the orthopedics sector. Meanwhile, financial stability depends on the consistency of component supplies from Asia and US trade policy.

Dana dhuwit perusahaan: Bone Biologics Inc (BBLG) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Bone Biologics Corp. (BBLG)

Analisis wiwitan perusahaan:Bone Biologics Inc BBLG
Produk merek Bone Biologics Corp

Liquidity serves as the foundation for the survival of Bone Biologics (BBLG) during its clinical trial period. The dynamics of operating cash flow reflect the company's ability to fund the operation of contract manufacturing and the auditing of bone matrices. This metric aggregates available cash, allowing for an assessment of the burn rate relative to the pace of product development. Excess funds without reinvestment signal a decline in asset management efficiency. This balance determines the fair value of the business through the lens of financial autonomy.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|Dhuwit awis perusahaan STXS|Cadangan dhuwit perusahaan Neuronetics, Inc. STIM|Volume dana dhuwit perusahaan SGHT|Dhuwit awis perusahaan Orchestra BioMed OBIO|Dana dhuwit perusahaan Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Total volume dana dhuwit perusahaan|ZJYL - Dana dhuwit perusahaan|VANI (vivani.com) - Dhuwit awis lan setara dhuwit awis perusahaan|XTNT (Xtant Medical Inc) - Dhuwit awis perusahaan|Cadangan dhuwit perusahaan n1mtc.com (NMTC)|Dana dhuwit perusahaan modular-medical.com|Dhuwit awis lan setara dhuwit awis perusahaan MYO (Myomo)|Volume dana dhuwit perusahaan COCH|VVOS (Vivos Therapeutics, Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan envveno.com NVNO|SINT - Dhuwit awis perusahaan|Tenon Medical Inc. - Volume dana dhuwit perusahaan|LFWD: Dana dhuwit perusahaan|Autonomix (AMIX) - Dana dhuwit perusahaan|IVF - Aset likuid perusahaan|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)